SSE Ticker: 688166

Brightgene Bio-Medical Technology Co., Ltd.

博瑞医药

Authorized Representative: 袁建栋

Board: Star Market

Industry Classification: Biomedicine

Shanghai Stock Connect added 21 stocks on the Science and Technology Innovation Board yesterday_ Oriental Fortune Net

Post date May 6, 2022 — 10:20 Post Lock

Gloria Spectrum completes a new round of financing of hundreds of millions of yuan, accelerating to lead the financing of innovative clinical products from multiple omics sources – yqqlm

Post date May 5, 2022 — 12:51 Post Lock

31 Sci-tech Innovation Board stocks received northbound funds to increase their positions_Oriental Fortune Network

Post date April 28, 2022 — 11:28 Post Lock

Borui Pharmaceutical (688166): Resolution of the 7th meeting of the 3rd Supervisory Committee- CFi.CN Zhongcai Network

Post date April 27, 2022 — 19:28 Post Lock

CDB Securities maintains the recommendation rating of Borui Pharmaceutical: Rapid growth in annual performance awaits the release of production capacity

Post date April 26, 2022 — 23:53 Post Lock

Boji Pharma (300404): CITIC Securities Co., Ltd.'s special inspection opinion on the deposit and use of funds raised by Boji Pharma Technology Co., Ltd. in 2021- CFi.CN Zhongcai.com

Post date April 26, 2022 — 15:02 Post Lock

Boji Pharmaceutical (300404): Special Report on the Deposit and Use of Raised Funds in 2021 CFi.CN Zhongcai Network

Post date April 26, 2022 — 14:56 Post Lock

Slack (300382): The company renews the appointment of the 2022 audit institution CFi.CN Zhongcai Network

Post date April 25, 2022 — 13:08 Post Lock

Slack (300382): The company renews the appointment of the 2022 audit institution CFi.CN Zhongcai Network

Post date April 25, 2022 — 11:36 Post Lock

National Core Technology (688262): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network

Post date April 21, 2022 — 22:46 Post Lock

Borui Pharmaceutical (688166): Held the 2021 Annual Results Briefing-CFi.CN Zhongcai Network

Post date April 19, 2022 — 18:19 Post Lock

Feiliks (300240): intends to re-appoint the accounting firm in 2022 CFi.CN Zhongcai Network

Post date April 19, 2022 — 05:06 Post Lock

Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: the scale effect improves the connection between new and old varieties_Oriental Fortune Network

Post date April 18, 2022 — 13:40 Post Lock

Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: scale effect improves the connection between new and old varieties

Post date April 18, 2022 — 13:40 Post Lock

Southwest Securities: Overweight rating for Borui Pharmaceuticals

Post date April 17, 2022 — 17:41 Post Lock

Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm

Post date April 17, 2022 — 17:34 Post Lock

Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm

Post date April 17, 2022 — 17:34 Post Lock

Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations

Post date April 17, 2022 — 17:32 Post Lock

Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm

Post date April 16, 2022 — 01:49 Post Lock

Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares

Post date April 15, 2022 — 21:37 Post Lock

Want to see more data? Registered subscribers can see all the data.